Oncology
From Chemo to Advanced Therapies: New Frontiers in Oncology
Serene Lee
Nice Insight
PAO-25-30-29Apr 15, 2025
Gene Therapy
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-28Apr 14, 2025
First-in-Class Drugs
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-27Apr 09, 2025
Supply Chain
Building Resilient Pharma Supply Chains in an Uncertain World
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-26Mar 31, 2025
Cell Therapy
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
April Stanley, MS MBA; Sophie Lutter, Ph.D.
Nice Insight
PAO-03-25-NI-07Mar 26, 2025
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Cynthia A. Challener, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
PAO-03-25-NI-06Mar 26, 2025
SUT
From Niche to Necessity: How Single-Use Transformed Biomanufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-25Mar 24, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24Mar 21, 2025
Genomics
Genomics and the Next Era of Precision Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-23Mar 20, 2025
Aging
Resetting the Biological Clock: OKSM and the Reversal of Aging
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-22Mar 19, 2025
Global Trials
Clinical Trials Without Borders: The Evolution of Global Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-21Mar 14, 2025
LOGIC GATES
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-03Mar 14, 2025
Space
The Final Frontier: Biomanufacturing in Space
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-20Mar 13, 2025
Advocacy
From Patients to Partners: The Rising Power of Advocacy in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-19Mar 13, 2025
DCTs
Accelerating Patient Access Through Decentralized Clinical Trials
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-18Mar 12, 2025
Pandemic
Global Health at a Crossroads and the Future of Pandemic Preparedness
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-17Mar 12, 2025
Biomarkers
The Biomarker Revolution in Medicine and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-16Mar 10, 2025
NTDs
Working Toward a Future Without Neglected Tropical Diseases
Serene Lee
Nice Insight
PAO-25-30-15Mar 07, 2025
Diversity
Fighting for Diversity and Equity in Pharma and Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-05Mar 06, 2025
Collaboration
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-14Mar 03, 2025